View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EQS-News: A.H.T. Syngas Technology N.V.: GBC AG nimmt Coverage von A.H...

EQS-News: A.H.T Syngas Technology N.V. / Schlagwort(e): Research Update A.H.T. Syngas Technology N.V.: GBC AG nimmt Coverage von A.H.T. Syngas Technology N.V. mit Kaufempfehlung und einem Kursziel von EUR 37,50 auf 26.04.2024 / 12:25 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 26. April 2024   A.H.T. Syngas Technology N.V.: GBC AG nimmt Coverage von A.H.T. Syngas Technology N.V. mit Kaufempfehlung und einem Kursziel von EUR 37,50 auf Die A.H.T. Syngas Technology N.V. ("AHT") (ISIN NL0010872388, WKN A12AGY), ein Entwickler und Bet...

 PRESS RELEASE

Atour Lifestyle Holdings Limited Filed 2023 Annual Report on Form 20-F

Atour Lifestyle Holdings Limited Filed 2023 Annual Report on Form 20-F SHANGHAI, China, April 26, 2024 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading hospitality and lifestyle company in China, today announced that the Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (“SEC”) on April 26, 2024. The annual report is available on the Company’s investor relations website at , and on the SEC’s website at . The Company will provide hard copie...

 PRESS RELEASE

Ocugen to Present on Modifier Gene Therapy Platform at Association for...

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Company will present on its innovative modifier gene therapy platform, including OCU400 for the treatment of retinitis pigmentosa (Phase 3 LiMeliGhT clinical trial), OCU410 for the treatment of geographic atrophy (P...

 PRESS RELEASE

Archrock Announces Quarterly Cash Dividend and Extends Share Repurchas...

Archrock Announces Quarterly Cash Dividend and Extends Share Repurchase Authorization HOUSTON, April 26, 2024 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE: AROC) (“Archrock” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.165 per share of common stock, or $0.66 per share on an annualized basis. The first quarter 2024 dividend will be paid on May 14, 2024 to all stockholders of record on May 7, 2024. The first quarter 2024 dividend per share amount is consistent with Archrock’s fourth quarter 2023 dividend and represents a year-over-year...

STAR CM Holdings Ltd: 1 director

A director at STAR CM Holdings Ltd sold 1,962,700 shares at 3.839HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Ramelius Resources Limited: 1 director

A director at Ramelius Resources Limited sold 691,503 shares at 2.038AUD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

 PRESS RELEASE

ExxonMobil Announces First-Quarter 2024 Results

SPRING, Texas--(BUSINESS WIRE)-- Exxon Mobil Corporation (NYSE:XOM): Results Summary                       Dollars in millions (except per share data) 1Q24 4Q23 Change vs 4Q23 1Q23 Change vs 1Q23 Earnings (U.S. GAAP) 8,220 7,630 +590 11,430 -3,210 Earnings Excluding Identified Items (non-GAAP) 8,220 9,963 -1,743 11,618 -3,398             ...

 PRESS RELEASE

PunaMusta Media -konsernin liiketoimintakatsaus tammi-maaliskuulta 202...

PunaMusta Media -konsernin liiketoimintakatsaus tammi-maaliskuulta 2024 PUNAMUSTA MEDIA OYJ PÖRSSITIEDOTE 26.4.2024 KLO 13.30    LIIKEVAIHTO JA KÄYTTÖKATE HEIKKENIVÄT VUODEN 2024 ENSIMMÄISELLÄ VUOSINELJÄNNEKSELLÄ PunaMusta Media Oyj julkistaa liiketoimintakatsauksen, jossa esitetään yhtiön taloudellista kehitystä koskevat keskeiset tiedot. Liiketoimintakatsauksen luvut ovat tilintarkastamattomia. PunaMusta Media Oyj on 28.3.2024 toteuttanut tytäryhtiöidensä Sanomalehti Karjalainen Oy:n, Karelia Viestintä Oy:n ja PunaMusta Paikallismediat Oy:n koko osakekantojen myynnin Keskisuomalainen O...

 PRESS RELEASE

Resolutions of Harvia Plc's Annual General Meeting on 26 April 2024

Resolutions of Harvia Plc's Annual General Meeting on 26 April 2024 STOCK EXCHANGE RELEASE 26 April 2024 at 1.30 p.m. EEST Resolutions of Harvia Plc's Annual General Meeting on 26 April 2024 Harvia Plc’s Annual General Meeting, held today on 26 April 2024, approved the financial statements and discharged the members of the Board of Directors and the company’s CEO from liability for the financial year 2023. The Annual General Meeting approved in an advisory decision the remuneration report for governing bodies. The Annual General Meeting resolved to reject the revised...

 PRESS RELEASE

Ault Alliance No Longer Seeking to Sell Midwest Hotel Portfolio

LAS VEGAS--(BUSINESS WIRE)-- (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today announced that it has ended the marketing process for its four hotels owned and operated by its wholly owned subsidiary, Ault Global Real Estate Equities, Inc. (“AGREE”). As a result, it was determined that the AGREE assets and liabilities previously presented as assets and liabilities held for sale within the Company’s balance sheet will no longer meet the held for sale criteria. Assets of $91.0 million and liabilities of $70.4 million as of December 31, 2023 were repo...

 PRESS RELEASE

Man Group PLC : Form 8.3 - Redrow plc

Man Group PLC : Form 8.3 - Redrow plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this for...

 PRESS RELEASE

Man Group PLC : Form 8.3 - Barratt Developments plc

Man Group PLC : Form 8.3 - Barratt Developments plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant secur...

Vitura Health Ltd: 1 director

A director at Vitura Health Ltd sold 10,000,000 shares at 0.110AUD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Websolute S.p.A: 2 directors

Two Directors at Websolute S.p.A bought 41,800 shares at between 0.925EUR and 0.978EUR. The significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...

ABGSC IT Research ... (+3)
  • ABGSC IT Research
  • Daniel Thorsson
  • Simon Granath
 PRESS RELEASE

Man Group PLC : Form 8.3 - Tyman plc

Man Group PLC : Form 8.3 - Tyman plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this form...

Moody's Ratings assigns (P)Baa1/(P)P-2 backed senior unsecured ratings...

Moody's Ratings (Moody's) has assigned (P)Baa1/(P)P-2 long-term and short-term foreign and local currency backed senior unsecured MTN program ratings to CSCIF Hong Kong Limited's USD4 billion medium-term note (MTN) program. CSCIF Hong Kong Limited is incorporated in the British Virgin Islands and ...

 PRESS RELEASE

Novo Nordisk A/S – Total number of voting rights and share capital in ...

Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024 Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred. Referring to Company Announcement no 32/2024 dated 24 April 2024, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 26 April 2024...

 PRESS RELEASE

Mise à disposition du Document d’Enregistrement Universel 2023

Mise à disposition du Document d’Enregistrement Universel 2023 Mise à disposition du Document d’Enregistrement Universel 2023 Paris, le 26 avril 2024 : La société MRM (Euronext code ISIN FR00140085W6) annonce que son Document d’Enregistrement Universel 2023 a été déposé auprès de l'Autorité des Marchés Financiers (AMF) le 26 avril 2024. Il est disponible sur le site Internet de la Société à l’adresse ainsi que sur le site Internet de l'AMF. Les informations suivantes sont intégrées dans le Document d’Enregistrement Universel : le rapport financier annuel 2023 et le rapport sur le gouvern...

 PRESS RELEASE

Chevron Reports First Quarter 2024 Results

SAN RAMON, Calif.--(BUSINESS WIRE)-- Chevron Corporation (NYSE: CVX) reported earnings of $5.5 billion ($2.97 per share - diluted) for first quarter 2024, compared with $6.6 billion ($3.46 per share - diluted) in first quarter 2023. Foreign currency effects increased earnings by $85 million. Adjusted earnings of $5.4 billion ($2.93 per share - diluted) in first quarter 2024 compared to adjusted earnings of $6.7 billion ($3.55 per share - diluted) in first quarter 2023. See Attachment 4 for a reconciliation of adjusted earnings. Earnings & Cash Flow Summary     Unit ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch